Article metrics

Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study

 

Online download statistics by month:

Online download statistics by month: January 2022 to May 2022

AbstractFullPdf
Jan 2022572579185
Feb 2022424426136
Mar 202222422887
Apr 202221622499
May 202227728891
Total17131745598